Biorasi Welcomes Hematologist Dr. Robert S. Negrin to Scientific Advisory Board
May 4, 2021MIAMI–(BUSINESS WIRE)–#clinicaltrials—Biorasi, a leading global full-service contract research organization (CRO), is proud to announce the appointment of Robert S. Negrin, MD to the position of Scientific Advisory Board (SAB) member. In this role, Dr. Negrin will provide clinical expertise and leadership for hematology clinical studies and related areas at Biorasi.
“Dr. Negrin’s experience in blood and marrow transplantation will bring a fresh perspective in our approach to clinical trials for hematology are rare blood diseases,” said Omar Ibrahim, PhD, Project Manager at Biorasi. “His presence as an SAB board member will optimize our approach to clinical trial solutions and build upon our core competencies of speed, flexibility, and quality.”
Dr. Negrin is one of four SAB members that will be joining Biorasi in 2021. This group of clinicians and researchers includes experts in the fields of hematology, dermatology, neurology, and oncology, working together with Biorasi’s Board of Directors and leadership.
“Biorasi’s Scientific Advisory Board gives us access to world-class expertise in our key therapeutic areas,” said Chris O’Brien, CEO at Biorasi. “Dr. Negrin certainly fits the bill, and I am delighted to welcome him to the company.”
Dr. Negrin is a Professor of Medicine and former Chief of the Division of Blood and Marrow Transplantation at Stanford University. Dr. Negrin’s current research focuses on the fundamental understanding of graft vs. host and graft vs. tumor reactions, with an emphasis on immune regulatory mechanisms. He has previously served as the President of the International Society of Cellular Therapy and the American Society of Blood and Marrow Transplantation. Dr. Negrin received his MD from Harvard Medical School and trained in Internal Medicine and Hematology at Stanford University.
“I am very excited to begin working alongside Biorasi,” said Dr. Negrin. “My new role as SAB will provide the opportunity to promote innovation and evolution in hematology studies and other clinical research.”
About Biorasi
Biorasi is a customer-focused, full-service, contract research organization (CRO) that delivers fast and flexible solutions across global clinical trials to maximize speed-to-market for its sponsors. As the leader in neurology, nephrology, dermatology, and the rare and urgent disease market, Biorasi sets new benchmarks for speed, agility, and quality in patient enrollment, decentralized trials, and data transparency. Contact Biorasi at [email protected] / (786) 388-0700.
Contacts
Adam Gottlieb (954) 410-3654 [email protected]